Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)

the PREVAC study team

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.

Original languageEnglish (US)
Article number583
JournalTrials
Volume22
Issue number1
DOIs
StatePublished - Dec 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021.

PubMed: MeSH publication types

  • Published Erratum

Fingerprint

Dive into the research topics of 'Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)'. Together they form a unique fingerprint.

Cite this